Interleukin 17 in early invasive breast cancer

INTRODUCTION: Interleukin 17 (IL-17) has a key role in inflammatory responses. Increased serum concentrations of IL-17 have been reported in patients with different types of cancer. Some studies suggest antitumor activity of IL-17 while others speak in favor of its association with poorer prognosis....

Descripción completa

Detalles Bibliográficos
Autores principales: Popović, Marina, Dedić Plavetić, Natalija, Vrbanec, Damir, Marušić, Zlatko, Mijatović, Davor, Kulić, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328740/
https://www.ncbi.nlm.nih.gov/pubmed/37427128
http://dx.doi.org/10.3389/fonc.2023.1171254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328740/
https://www.ncbi.nlm.nih.gov/pubmed/37427128
http://dx.doi.org/10.3389/fonc.2023.1171254

Ejemplares similares